Rudolf Kwan - Jul 20, 2022 Form 4 Insider Report for Athenex, Inc. (ATNXQ)

Role
EVP, Chief Medical Officer
Signature
/s/ Steven Adams, Attorney-in-Fact
Stock symbol
ATNXQ
Transactions as of
Jul 20, 2022
Transactions value $
$0
Form type
4
Date filed
7/21/2022, 05:22 PM
Previous filing
Jul 18, 2022
Next filing
Aug 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ATNXQ Common Stock 268K Jul 20, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNXQ Stock Option (Right to Buy) Award $0 +75K $0.00 75K Jul 20, 2022 Common Stock 75K $0.67 Direct F6
holding ATNXQ Stock Option (Right to Buy) 96K Jul 20, 2022 Common Stock 96K $4.55 Direct
holding ATNXQ Stock Option (Right to Buy) 48K Jul 20, 2022 Common Stock 48K $4.55 Direct
holding ATNXQ Stock Option (Right to Buy) 120K Jul 20, 2022 Common Stock 120K $4.55 Direct
holding ATNXQ Stock Option (Right to Buy) 48K Jul 20, 2022 Common Stock 48K $4.55 Direct
holding ATNXQ Stock Option (Right to Buy) 200K Jul 20, 2022 Common Stock 200K $5.50 Direct
holding ATNXQ Stock Option (Right to Buy) 120K Jul 20, 2022 Common Stock 120K $7.50 Direct
holding ATNXQ Stock Option (Right to Buy) 140K Jul 20, 2022 Common Stock 140K $11.00 Direct
holding ATNXQ Stock Option (Right to Buy) 120K Jul 20, 2022 Common Stock 120K $17.30 Direct
holding ATNXQ Stock Option (Right to Buy) 120K Jul 20, 2022 Common Stock 120K $13.17 Direct F1
holding ATNXQ Stock Option (Right to Buy) 140K Jul 20, 2022 Common Stock 140K $12.45 Direct F2
holding ATNXQ Stock Option (Right to Buy) 70K Jul 20, 2022 Common Stock 70K $3.80 Direct F3
holding ATNXQ Restricted Stock Units 70K Jul 20, 2022 Common Stock 70K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in four equal annual installments beginning on February 28, 2020.
F2 This option vests in four equal annual installments beginning on June 5, 2021.
F3 The option vests in four equal annual installments beginning on August 3, 2022.
F4 Each restricted stock unit represents a contingent right to receive one share of stock.
F5 The restricted stock units vest in four equal annual installments beginning on August 3, 2022.
F6 This option vests in four equal annual installments beginning on July 20, 2023.